Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Irrisol
- Development stage
- Unknown
- Lead developer
- Imuna Pharm
- Administration
- Intraarticular, Topical
01
Overview
Irrisol is a brand of sterile, nonpyrogenic, isotonic irrigation solutions developed by Imuna Pharm. The product line includes Sodium Chloride 0.9% Irrisol, Ringer Irrisol, and AQUA Irrisol, with a Lactated Ringer's formulation in development. These solutions are designed for topical wound irrigation and cleansing, helping to hydrate wounds, remove debris and bacteria, assist in visual inspection, and promote healing. The planned Lactated Ringer's formulation is intended for use as an irrigating fluid during joint examinations and endoscopic procedures, providing a transparent medium that mimics the electrolyte composition of synovial fluid.
- Brand names
- Irrisol
- Other names
- AQUA IrrisolAQUA irrigation solutionRinger IrrisolRinger irrigation solutionRinger lactateSodium chloride 0.9% IrrisolSodium chloride 0.9% irrigation solution
Beyond the preview
Go deeper on Irrisol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Irrisol.